bioMerieux is headquartered in Marcy l'Etoile, France.
bioMerieux disclosed revenue of 3,980M EUR for 2024 and 3,675M EUR for 2023.
bioMerieux has 14,147 employees.
bioMerieux is a life science company.
bioMerieux was founded in 1963.
376 Chemin De l'Orme,
Marcy l'Etoile,
69280
France,
+33 4 78 87 20 00
www.biomerieux.com
bioMerieux is a provider in the field of in vitro diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening, monitoring, and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy-l'Étoile, France.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | 20 | - | 1 | - | - | - | 21 |
| vol | $863M | $863M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 21 | ||||||||
| Legal | Deals |
|---|---|
|
Gide Loyrette Nouel |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
